Expression of stem cell factor in basal cell carcinoma

British Journal of Dermatology

Volumn 137, Issue 5, 1997, Pages 709-713

  Yamamoto, T ^a   Katayama, I ^a   Nishioka, K ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KERATINOCYTE; MALE; MAST CELL; PRIORITY JOURNAL; SKIN FIBROSIS; STROMA; TRICHOEPITHELIOMA;

EID: 0030666787     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb01106.x     Document Type: Article

References (39)

1. Stamp GWH. Tenascin distribution in basal cell carcinoma. J Cutan Pathol 1989; 159: 225-9.
2. Stamp GWH, Nasim M, Cardillo M et al. Transforming growth factor-β distribution in basal cell carcinoma: relationship to proliferation index. Br J Dermatol 1993; 129: 57-64.
3. Ponten F, Ren Z, Nister M et al. Epithelial-stromal interactions in basal cell cancer: the PDGF system. J Invest Dermatol 1994; 102: 304-9.
4. Flynn EA, Schwartz JL, Shklar G. Sequential mast cell infiltration and degranulation during experimental carcinogenesis. J Cancer Res Clin Oncol 1991; 117: 115-22.
5. Moore RD, Stevenson J, Schoenberg MD. The response of connective tissue associated with tumors of the skin. Am J Clin Pathol 1960; 34: 125-50.
6. Cohen MS, Rogers GS. The significance of mast cells in basal cell carcinoma. J Am Acad Dermatol 1995; 33: 514-17.
7. Bradding P. Human mast cell cytokines. Clin Exp Allergy 1996; 26: 13-19.
8. Coleman JW, Holliday MR, Kimber I et al. Regulation of mouse peritoneal mast cell secretary function by stem cell factor, IL-3 or IL-4. J Immunol 1993; 150: 556-62.
9. Columbo M, Horowitz EM, Botana LM et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 1992; 149: 599-608.
10. Tsai M, Shih L, Newlands GFJ et al. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J Exp Med 1991; 174: 125-31.
11. Meininger CJ, Yano H, Rottapel R et al. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 1992; 79: 958-62.
12. Valent P. The riddle of the mast cell: kit (CD-117)-ligand as the missing link? Immunol Today 1994; 15: 111-14.
13. Galli SJ, Tsai M, Wershil BK. The c-kit receptor, stem cell factor, and mast cells. Am J Pathol 1993; 142: 965-74.
14. Longley BJ, Morganroth S, Tyrell BA et al. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 1993; 128: 1302-7.
15. Hamann K, Haas N, Grabbe J et al. Expression of stem cell factor in cutaneous mastocytosis. Br J Dermatol 1995; 133: 203-8.
16. Yamamoto T, Katayama I, Nishioka K. Impaired expression of stem cell factor in dermatofibroma fibroblast. Acta Derm Venereol (Stockh) 1996; 76: 257-9.
17. Nishioka K, Kobayashi Y, Katayama I, Takijiri C. Mast cell numbers in diffuse scleroderma. Arch Dermatol 1987; 123: 205-8.
18. Yamamoto T, Katayama I, Nishioka K. Mast cell numbers in multiple dermatofibromas. Dermatology 1995; 190: 9-13.
19. McArdle JP, Roff BT, Muller HK, et al. The basal lamina in basal cell carcinoma. Bowen's disease, squamous cell carcinoma and keratoacanthoma. An immunoperoxidase study using an antibody to type collagen. Pathology 1984; 16: 67-72.
20. Stamp GWH, Pignatelli M. Distribution of β1, α1, α2 and α3 integrin chains in basal cell carcinomas. J Pathol 1991; 163: 307-13.
21. Hernandez AD, Hibbs MS, Postlethwaite AE. Establishment of basal cell carcinoma in culture: evidence for a basal cell carcinoma-derived factor(s) which stimulates fibroblasts to proliferate and release collagenase. J Invest Dermatol 1985; 85: 470-5.
22. Barsky SH, Grossman DA, Bhuta S. Desmoplastic basal cell carcinomas possess unique basement membrane-degrading properties. J Invest Dermatol 1987; 88: 324-9.
23. Goslen JB, Bauer EA. Basal cell carcinoma and collagenase. J Dermatol Surg Oncol 1986; 12: 812-17.
24. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985; 43: 175-203.
25. Roche WR. Mast cells and tumor angiogenesis: the tumor-mediated release of an endothelial growth factor from mast cells. Int J Cancer 1985; 36: 721-8.
26. Walsh LJ, Trinchieri G, Waldorf HA et al. Human dermal mast cells contain and release tumour necrosis factor-α, which induces endothelial leucocyte adhesion molecule-1. Proc Natl Acad Sci USA 1991; 88: 4220-4.
27. Galli SJ. New concepts about the mast cell. N Engl J Med 1993; 328: 257-75.
28. Subba RPV, Friedman MM, Atkins FM et al. Phagocytosis of mast cell granules by cultured fibroblasts. J Immunol 1983; 130: 341-9.
29. Battegay EJ, Raines EW, Colbert RT, Ross R. TNF-α stimulation of fibroblast proliferation. Dependence on platelet-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression. J Immunol 1995; 154: 6040-7.
30. Williams DE, Eisenman J, Baird A et al. Identification of a ligand for the c-kit protooncogene. Cell 1990; 63: 167-74.
31. Zsebo KM, Williams DA, Geissler EN et al. Stem cell factor (SCF) is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990; 63: 213-24.
32. Valent P, Spanblochl E, Sperr WR et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 1992; 80: 2237-42.
33. Grabbe J, Welker P, Dippep E et al. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res 1994; 287: 78-84.
34. Katayama I, Yokozeki H, Nishioka K. Induction and characterization of mast cell colonies by culture supernatants of retinoic acid-treated mouse keratinocytes. Int Arch Allergy Immunol 1993; 100: 328-32.
35. Morita E, Lee DG, Sugiyama M et al. Expression of c-kit ligand in human keratinocytes. Arch Dermatol Res 1994; 286: 273-7.
36. Weiss RR, Whitaker-Menezes D, Longley J et al. Human dermal endothelial cells express membrane-associated mast cell growth factor. J Invest Dermatol 1995; 104: 101-6.
37. Costa JJ, Demetri GD, Harrist TJ et al. Recombinant human stem cell factor (rhSCF) induces cutaneous mast cell activation and hyperplasia, and hyperpigmentation in humans in vivo (abstract). J Allergy Clin Immunol 1994; 93: 225.
38. Ruoss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for fibroblasts. J Clin Invest 1991; 88: 493-9.
39. Gordon JR, Galli SJ. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the FcεRI. Role for mast cell-derived transforming growth factor β and tumor necrosis factor-α. J Exp Med 1994; 180: 2027-37.